Latest Insider Transactions at Imara Inc. (IMRA)
This section provides a real-time view of insider transactions for Imara Inc. (IMRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IMARA Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IMARA Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,848
-0.2%
|
$6,848
$1.89 P/Share
|
|
Jan 14
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,707
-0.28%
|
$9,707
$1.91 P/Share
|
|
Jan 13
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,209
-0.21%
|
$7,209
$1.93 P/Share
|
|
Jan 12
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,634
-0.13%
|
$9,268
$2.02 P/Share
|
|
Jan 11
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,409
-0.07%
|
$4,818
$2.04 P/Share
|
|
Jan 10
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,751
-0.05%
|
$3,502
$2.0 P/Share
|
|
Jan 07
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,600
-0.42%
|
$29,200
$2.08 P/Share
|
|
Jan 06
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,257
-0.29%
|
$20,514
$2.16 P/Share
|
|
Jan 05
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,200
-0.23%
|
$16,400
$2.25 P/Share
|
|
Jan 04
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,459
-0.38%
|
$26,918
$2.34 P/Share
|
|
Jan 03
2022
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
44,665
-1.25%
|
$89,330
$2.34 P/Share
|
|
Dec 31
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
49,953
-1.37%
|
$99,906
$2.25 P/Share
|
|
Dec 30
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,858
-0.6%
|
$43,716
$2.29 P/Share
|
|
Dec 29
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,196
-0.41%
|
$30,392
$2.3 P/Share
|
|
Dec 28
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
24,580
-0.67%
|
$49,160
$2.34 P/Share
|
|
Dec 27
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
27,651
-0.74%
|
$55,302
$2.42 P/Share
|
|
Dec 23
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
23,961
-0.64%
|
$47,922
$2.41 P/Share
|
|
Dec 22
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,109
-0.53%
|
$40,218
$2.32 P/Share
|
|
Dec 21
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
41,222
-1.08%
|
$82,444
$2.32 P/Share
|
|
Dec 20
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
85,123
-1.1%
|
$170,246
$2.27 P/Share
|
|
Dec 16
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
44,993
-1.14%
|
$89,986
$2.23 P/Share
|
|
Dec 15
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
28,817
-0.73%
|
$57,634
$2.28 P/Share
|
|
Dec 14
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,093
-0.38%
|
$30,186
$2.56 P/Share
|
|
Dec 13
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,501
-0.44%
|
$35,002
$2.83 P/Share
|
|
Dec 10
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,667
-0.22%
|
$17,334
$2.83 P/Share
|
|
Dec 09
2021
|
New Enterprise Associates 14, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,666
-0.14%
|
$11,332
$2.95 P/Share
|
|
Jul 16
2021
|
Mark Chin Director |
BUY
Open market or private purchase
|
Indirect |
1,333,333
+36.26%
|
$7,999,998
$6.0 P/Share
|
|
Jul 16
2021
|
David P Bonita Director |
BUY
Open market or private purchase
|
Indirect |
1,666,666
+50.0%
|
$9,999,996
$6.0 P/Share
|
|
Jul 16
2021
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,666,666
+50.0%
|
$9,999,996
$6.0 P/Share
|
|
Dec 17
2020
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
4,999
-100.0%
|
$124,975
$25.0 P/Share
|
|
Dec 17
2020
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
4,999
+50.0%
|
$14,997
$3.15 P/Share
|
|
Dec 14
2020
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
1
-100.0%
|
$25
$25.0 P/Share
|
|
Dec 14
2020
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+50.0%
|
$3
$3.15 P/Share
|
|
Dec 11
2020
|
Michael Gray CFO & COO |
SELL
Open market or private sale
|
Direct |
1,250
-100.0%
|
$31,250
$25.0 P/Share
|
|
Dec 11
2020
|
Michael Gray CFO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+50.0%
|
$5,000
$4.92 P/Share
|
|
Mar 16
2020
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
625,000
+30.06%
|
$10,000,000
$16.0 P/Share
|
|
Mar 16
2020
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
829,348
+50.0%
|
-
|
|
Mar 16
2020
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+32.32%
|
$4,000,000
$16.0 P/Share
|
|
Mar 16
2020
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
273,411
+50.0%
|
-
|
|
Mar 16
2020
|
Pfizer Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
312,500
+17.42%
|
$5,000,000
$16.0 P/Share
|
|
Mar 16
2020
|
Pfizer Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,169,219
+35.23%
|
-
|
|
Mar 16
2020
|
Pfizer Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
76,003
+50.0%
|
-
|
|
Mar 16
2020
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
1,594,902
+38.64%
|
-
|
|
Mar 12
2020
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
937,500
+50.0%
|
$15,000,000
$16.0 P/Share
|